Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'tranylcypromine 2 pcpa hcl'

Search results for: 'tranylcypromine 2 pcpa hcl'

Items 71-80 of 111

Page
per page
  1. PJ34
    A3729 PJ34
    Target: PARP
    Summary: PARP-l inhibitor
      ≥50.9 mg/mL
  2. Bromodomain Inhibitor, (+)-JQ1
    A1910 Bromodomain Inhibitor, (+)-JQ1
     38 Citation
    Target: Bromodomains
    Summary: BET bromodomain inhibitor
      ≥22.85 mg/mL
  3. PJ34 hydrochloride
    A4159 PJ34 hydrochloride
    Summary: PARP inhibitor,potent and cell-permeable
      insoluble in H2O; insoluble in EtOH; ≥16.6 mg/mL
  4. 1,2,3,4,5,6-Hexabromocyclohexane
    A4510 1,2,3,4,5,6-Hexabromocyclohexane
    Summary: JAK2 tyrosine kinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥8.22 mg/mL
  5. Zebularine
    A1915 Zebularine
     1 Citation
    Target: DNA Methyltransferases|Cytidine deaminases
    Summary: DNA methylation inhibitor
      insoluble in EtOH; ≥50.7 mg/mL
  6. MK-4827 hydrochloride
    B1163 MK-4827 hydrochloride
    Summary: PARP1/PARP2 inhibitor
      Soluble in DMSO
  7. TCS PIM-1 1
    A4521 TCS PIM-1 1
    Summary: Pim-1 kinase inhibitor,ATP-competitve
      insoluble in H2O; insoluble in EtOH; ≥12.8 mg/mL
  8. S-Ruxolitinib (INCB018424)
    A4149 S-Ruxolitinib (INCB018424)
    Target: JAK
    Summary: JAK1/2 inhibitor,potent and selective
      Soluble in DMSO
  9. A-966492
    A4160 A-966492
    Target: PARP
    Summary: PARP-1/-2 inhibitor, highly potent
      ≥32.4 mg/mL
  10. CUDC-907
    A4097 CUDC-907
    Target: Histone Deacetylases (HDACs)|PI3K
    Summary: Potent PI3K/HDAC inhibitor
      ≥25.45 mg/mL

Items 71-80 of 111

Page
per page
Shop By
Now Shopping by
  1. Category Chromatin/Epigenetics Remove This Item
Clear All
Shopping Options
Category
  1. Bromodomain 5item
  2. Aurora Kinase 6item
  3. DNA Methyltransferase 4item
  4. HDAC 15item
  5. Histone Acetyltransferases 4item
  6. Histone Demethylases 6item
  7. Histone Methyltransferase 16item
  8. HIF 4item
  9. JAK 15item
  10. PARP 17item
  11. Pim 4item
  12. Protein Ser/Thr Phosphatases 9item
  13. Sirtuin 3item
  14. Sphingosine Kinase-2 1 item
  15. Polycomb repressive complex 1 item
  16. SUMOylation 1 item
Specificity
  1. Selective 40item
Reversibility
  1. Reversible 3item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Histone Deacetylases (HDACs) 11item
  3. PI3K 1 item
  4. Aurora Kinases 4item
  5. EZH2 2item
  6. Bromodomains 3item
  7. FLT3 1 item
  8. DOT1L 2item
  9. Pim 1 item
  10. Sir2-like Family Deacetylases (Sirtuins) 1 item
  11. STAT 1 item
  12. JAK 9item
  13. EZH1 1 item
  14. TNKS 1 item
  15. DNA Methyltransferases 2item
  16. SMYD2 1 item
  17. PARP 5item
  18. phosphatases 1 item
  19. G9a 1 item
  20. SETD7 1 item
  21. MNK 1 item
  22. AChE 1 item
  23. Cytidine deaminases 1 item
  24. c-RET 1 item
  25. HDAC 1 item
  26. KDM 1 item
  27. Histone Acetyltransferases (HATs) 1 item
  28. PHF 1 item
  29. SK 1 item
Reported Experiments
  1. Animal Experiments 42item
  2. Cell Experiments 33item
Related Disease
  1. Acute Myeloid Leukemia 2item
  2. Bladder Carcinoma 1 item
  3. Breast Cancer 6item
  4. Cancer 29item
  5. Cervical Cancer 2item
  6. Colon Cancer 3item
  7. Colon Carcinoma 1 item
  8. Colorectal Cancer 1 item
  9. Diabetes 1 item
  10. Glioma 2item
  11. Hepatocellular Carcinoma 1 item
  12. HIV 2item
  13. HIV Infections 1 item
  14. Immunological Diseases 1 item
  15. Inflammatory Bowel Disease 1 item
  16. Inflammatory Diseases 2item
  17. Leukemia 3item
  18. Lung Cancer 3item
  19. Lymphoma 1 item
  20. Melanoma 1 item
  21. Mixed Lineage Leukemia 2item
  22. Multiple Myeloma 2item
  23. Myelofibrosis 1 item
  24. Myeloma 1 item
  25. Non-small Cell Lung Cancer 2item
  26. Ovarian Cancer 1 item
  27. Pancreatic Cancer 2item
  28. Prostate Cancer 4item
  29. Psoriasis 1 item
  30. Renal Cell Carcinoma 1 item
  31. Rheumatoid Arthritis 2item
  32. Type 2 Diabetes 1 item